These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 14152269)

  • 21. STUDIES ON THE MECHANISM OF ACTION OF CYCLOPHOSPHAMIDE AND AB-132 WITH THE AID OF RADIOPROTECTIVE AGENTS.
    BACK N; BARDOS TJ; CHMIELEWICZ ZF; ACHTER E; MUNSON AE
    Life Sci (1962); 1964 Aug; 3():803-8. PubMed ID: 14201688
    [No Abstract]   [Full Text] [Related]  

  • 22. INTERACTION BETWEEN 5-HYDROXYTRYPTAMINE AND ANTITUMOURAL DRUGS.
    PALMA V; REYERS-DEGLIINNOCENTI I; GARATTINI S
    J Pharm Pharmacol; 1964 Nov; 16():770-1. PubMed ID: 14241150
    [No Abstract]   [Full Text] [Related]  

  • 23. ELECTRON MICROSCOPIC STUDIES OF ASCITES LYMPHOMA CELLS TREATED WITH DIFFERENT CHEMOTHERAPEUTICS.
    LAPIS K; GUBA F
    Acta Unio Int Contra Cancrum; 1964; 20():180-4. PubMed ID: 14151879
    [No Abstract]   [Full Text] [Related]  

  • 24. THE MULTIFOCAL LYMPHOMA SYNDROME IN AFRICAN CHILDREN IN KENYA.
    KHAN AG
    J Laryngol Otol; 1964 May; 78():480-98. PubMed ID: 14161125
    [No Abstract]   [Full Text] [Related]  

  • 25. REDUCTION OF THE TOXICITY OF "RADIOMIMETIC" ALKYLATING AGENTS IN RATS BY THIOL PRETREATMENT. II. MECHANISM OF PROTECTION.
    CALCUTT G; CONNORS TA; ELSON LA; ROSS WC
    Biochem Pharmacol; 1963 Aug; 12():833-7. PubMed ID: 14071540
    [No Abstract]   [Full Text] [Related]  

  • 26. Malignant lymphoma involving the jaw in African children: treatment with alkylating agents and actinomycin D.
    OETTGEN HF; CLIFFORD P; BURKITT D
    Cancer Chemother Rep; 1963 Apr; 28():25-34. PubMed ID: 13939520
    [No Abstract]   [Full Text] [Related]  

  • 27. [COMPARATIVE STUDY OF THE SPECTRUM OF ACTION OF ANTINEOPLASTIC PREPARATIONS OF THE ALKYLATING AGENT GROUP ON TRANSPLANTABLE TUMORS IN MICE].
    BOKAEVA SS
    Biull Eksp Biol Med; 1965 Mar; 59():86-8. PubMed ID: 14310877
    [No Abstract]   [Full Text] [Related]  

  • 28. [TUMOR INHIBITORY, HEMATOLOGICAL AND TOXICOLOGICAL EFFECTS OF 1,6-DIBROMO-1,6-DIDESOXY-D-MANNITOL].
    CSANYI E; HORVATH PI; INSTITORIS L
    Arzneimittelforschung; 1964 Jun; 14():670-3. PubMed ID: 14249065
    [No Abstract]   [Full Text] [Related]  

  • 29. IN VITRO TEST SYSTEMS FOR CANCER CHEMOTHERAPY. 3. PRELIMINARY STUDIES OF SPONTANEOUS MAMMARY TUMORS IN MICE.
    DIPAOLO JA
    Cancer Chemother Rep; 1965 Feb; 44():19-24. PubMed ID: 14294807
    [No Abstract]   [Full Text] [Related]  

  • 30. [THE INFLUENCE OF PRELIMINARY TREATMENT OF RATS WITH ALKYLATING SUBSTANCES AND OTHER TOXINS ON THE GROWTH OF YOSHIDA SARCOMA].
    SCHMAEHL D; SATTLER W
    Arzneimittelforschung; 1964 Jul; 14():746-50. PubMed ID: 14344711
    [No Abstract]   [Full Text] [Related]  

  • 31. [ON THE CARCINOSTATIC EFFECTS OF AMINOALKYLATING COMPOUNDS. 1. ON CYTOSTATICS].
    SCHOENENBERGER H; ADAM A
    Arzneimittelforschung; 1964 Oct; 14():1168. PubMed ID: 14343486
    [No Abstract]   [Full Text] [Related]  

  • 32. PLASMA CELL NEOPLASM ARISING IN A CAF MOUSE. CHARACTERISTICS AND RESPONSE TO CERTAIN CHEMOTHERAPEUTIC AGENTS.
    YANCEY ST
    J Natl Cancer Inst; 1964 Sep; 33():373-82. PubMed ID: 14207853
    [No Abstract]   [Full Text] [Related]  

  • 33. STUDIES WITH THE MURINE LEUKEMOGENIC RAUSCHER VIRUS. II. CHEMOTHERAPY OF VIRUS-INDUCED LYMPHOID LEUKEMIA.
    CHIRIGOS MA; RAUSCHER FJ; KAMEL IA; FANNING GR; GOLDIN A
    Cancer Res; 1963 Nov; 23():1646-50. PubMed ID: 14098904
    [No Abstract]   [Full Text] [Related]  

  • 34. THE TREATMENT OF MALIGNANT DISEASE BY REGIONAL CHEMOTHERAPY.
    JOHNSTON ID
    Ulster Med J; 1963 Dec; 32(2):151-9. PubMed ID: 14105942
    [No Abstract]   [Full Text] [Related]  

  • 35. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. 3. TOXICITY DATA ON MONKEYS AND DOGS.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:1017+. PubMed ID: 14278900
    [No Abstract]   [Full Text] [Related]  

  • 36. [CYTOSTATIC THERAPY WITH ALKYLATING AGENTS FOR MALIGNANT TUMORS].
    SCHUMACHER K; LANGE J
    Dtsch Med J; 1964 Nov; 15():761-5. PubMed ID: 14329920
    [No Abstract]   [Full Text] [Related]  

  • 37. [ON THE PATHOGENESIS OF INDUCED BRAIN TUMORS IN MICE].
    ARKHANGELSKII VV
    Vopr Neirokhir; 1964; 28():5-9. PubMed ID: 14225786
    [No Abstract]   [Full Text] [Related]  

  • 38. [STUDIES ON THE RELATIONSHIP BETWEEN ALPHA-OMEGA SUBSTITUTION AND CYTOSTATIC ACTION OF SOME SUGAR ALCOHOL DERIVATIVES AND OF 1,6-DIBROMO-1,6-DIDESOXY-D-MANNITOL].
    INSTITORIS L; HORVATH PI
    Arzneimittelforschung; 1964 Jun; 14():668-70. PubMed ID: 14249064
    [No Abstract]   [Full Text] [Related]  

  • 39. EFFECT OF PEPTIDES OF L-SARCOLYSIN ON A SPECTRUM OF ANIMAL TUMORS.
    SUGUIRA K
    Can Res Suppl; 1965 Apr; ():494-521. PubMed ID: 14289746
    [No Abstract]   [Full Text] [Related]  

  • 40. AURANTIN--A COMPLEX ANTIBIOTIC SUBSTANCE OF THE ACTINOMYCIN GROUP: ITS PROPERTIES AND RESULTS OF CLINICAL TRIALS ON VARIOUS TYPES OF NEOPLASMS.
    PLANELLES JJ; SOLOVYEVA YV; BELOVA ZN; SILAEV AB; EBERT MK; GRACHEVA NP; KHARITONOVA AM; GOSHEVA AE; AKOPYANTS SS
    Acta Unio Int Contra Cancrum; 1964; 20():297-9. PubMed ID: 14151914
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.